Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307419/
https://www.ncbi.nlm.nih.gov/pubmed/37387820
http://dx.doi.org/10.1155/2023/9830309
_version_ 1785066042970603520
author and Alternative Medicine, Evidence-Based Complementary
author_facet and Alternative Medicine, Evidence-Based Complementary
author_sort and Alternative Medicine, Evidence-Based Complementary
collection PubMed
description
format Online
Article
Text
id pubmed-10307419
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103074192023-06-29 Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307419/ /pubmed/37387820 http://dx.doi.org/10.1155/2023/9830309 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Alternative Medicine, Evidence-Based Complementary
Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
title Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
title_full Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
title_fullStr Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
title_full_unstemmed Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
title_short Retracted: Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI
title_sort retracted: investigating the effects of dapagliflozin on cardiac function, inflammatory response, and cardiovascular outcome in patients with stemi complicated with t2dm after pci
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307419/
https://www.ncbi.nlm.nih.gov/pubmed/37387820
http://dx.doi.org/10.1155/2023/9830309
work_keys_str_mv AT andalternativemedicineevidencebasedcomplementary retractedinvestigatingtheeffectsofdapagliflozinoncardiacfunctioninflammatoryresponseandcardiovascularoutcomeinpatientswithstemicomplicatedwitht2dmafterpci

Ejemplares similares